These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5621078)

  • 1. Pulmonary hypertension.
    Blount SG; Vogel JH
    Mod Concepts Cardiovasc Dis; 1967 Nov; 36(11):61-6. PubMed ID: 5621078
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vasodilation in children with left-right shunt. Effect of tolazoline].
    Netz H
    Fortschr Med; 1986 Mar; 104(10):213-5. PubMed ID: 3699647
    [No Abstract]   [Full Text] [Related]  

  • 3. Persistent pulmonary hypertension in a newborn with congenital diaphragmeatic hernia: successful management with tolazoline.
    Levy RJ; Rosenthal A; Freed MD; Smith CD; Eraklis A; Nadas AS
    Pediatrics; 1977 Nov; 60(5):740-2. PubMed ID: 917638
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute effect of oral prostacyclin and inhaled nitric oxide on pulmonary hypertension in children.
    Ichida F; Uese K; Hashimoto I; Hamamichi Y; Tsubata S; Fukahara K; Murakami A; Miyawaki T
    J Cardiol; 1997 Apr; 29(4):217-24. PubMed ID: 9127838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The persistence of foetal circulation. Neonatal pulmonary arterial hypertension. Favourable action of tolazoline (author's transl)].
    Monin P; Vert P
    Nouv Presse Med; 1978 Sep; 7(32):2853-4, 2859-61. PubMed ID: 714666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disorders of the pulmonary circulation in the child].
    Vogel A
    Beitr Pathol Anat; 1967; 136(2):133-64. PubMed ID: 5616727
    [No Abstract]   [Full Text] [Related]  

  • 7. [Oxygen and tolazoline as vasodilators in pulmonary arterial hypertension secondary to high pulmonary blood flow].
    Salgado-Escobar JL; Ledesma-Velasco M; Munayer-Calderón J; Núñez-Garduño D; Salas-López ME; Rodríguez-Hernández L
    Bol Med Hosp Infant Mex; 1987 Mar; 44(3):137-42. PubMed ID: 3580096
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary and secondary pulmonary hypertension in childhood: a clinicopathological reappraisal.
    Haworth SG
    Curr Top Pathol; 1983; 73():91-152. PubMed ID: 6884095
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pulmonary hypertension in the surgery of congenital heart defects].
    Burakovskiĭ VI; Fal'kovskiĭ GE; Plotnikova LR; Gordonova MI; Gorchakova AI
    Ter Arkh; 1983; 55(1):81-6. PubMed ID: 6836533
    [No Abstract]   [Full Text] [Related]  

  • 10. [Causation and management of pulmonary hypertensive crisis after open heart surgery].
    Nishigaki K; Hirose H; Matsuda H; Nakano S; Kishimoto H; Nomura F; Shimada Y; Kawashima Y
    Nihon Kyobu Geka Gakkai Zasshi; 1986 Feb; 34(2):135-9. PubMed ID: 3722910
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pulmonary hypertension in pediatric heart surgery].
    Falcone N
    Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):462-4. PubMed ID: 11792301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anesthesia and congenital heart defects.
    Allen HD
    Contemp Anesth Pract; 1980; 2():39-56. PubMed ID: 7438758
    [No Abstract]   [Full Text] [Related]  

  • 13. Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease.
    Limsuwan A; Khosithseth A; Wanichkul S; Khowsathit P
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):98-104. PubMed ID: 19089967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary hypertension in shunt heart defects--indication for surgery and results].
    Bock K; Meister EM; Schneider P; Häusler HJ
    Kinderarztl Prax; 1981 Aug; 49(8):402-8. PubMed ID: 7289411
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacology of tolazoline.
    Ward RM
    Clin Perinatol; 1984 Oct; 11(3):703-13. PubMed ID: 6386273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary hypertension in congenital cardiopathies. Surgical considerations].
    Villagra F; Sánchez PA
    Rev Esp Cardiol; 1982; 35(6):489-92. PubMed ID: 7184083
    [No Abstract]   [Full Text] [Related]  

  • 17. [Apoptotic dysregulation in pulmonary hypertension due to congenital heart disease].
    Lévy M; Bonnet D; Vouhé PR
    Arch Pediatr; 2008 Jun; 15(5):698-701. PubMed ID: 18582719
    [No Abstract]   [Full Text] [Related]  

  • 18. The pharmacologic control of the pulmonary circulation in pulmonary hypertension.
    Peter RH; Rubin L
    Adv Intern Med; 1984; 29():495-520. PubMed ID: 6369934
    [No Abstract]   [Full Text] [Related]  

  • 19. [Follow-up studies of pulmonary hypertension in congenital heart diseases and its manifestations in surgical considerations among infant patients].
    Taguchi K
    Kyobu Geka; 1965 Aug; 18(9):606-17. PubMed ID: 5890972
    [No Abstract]   [Full Text] [Related]  

  • 20. [Identification and localization of banding of the pulmonary artery by bidimensional echocardiography].
    Fermont L; Batisse A; Piéchaud JF; Roguin N; Ribierre M; Kachaner J
    Arch Mal Coeur Vaiss; 1982 Feb; 75(2):189-95. PubMed ID: 6176206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.